Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
Acta Materia Medica · 2022
DOI: 10.15212/amm-2022-0011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Materia Medica, 2022. Verfasst von Shi-Bing Zhang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Silybin (SB), a natural flavonoid isolated from Silybum marianum , has been used to treat hepatic fibrosis in clinical settings and as a dietary supplement, because of its hepatoprotective potential. Numerous studies have shown that SB also exerts promising anticancer effects; however, the anticancer targets of SB and the underlying mechanism were unclear. Herein, we found that SB significantly inhibited the proliferation of non-small cell lung cancer without causing cytotoxicity toward normal Beas-2B bronchial epithelial cells. Mechanistically, SB binds the F-box protein Skp2 and disrupts Skp1-Skp2 interaction, thereby decreasing Skp2 protein levels, inducing accumulation of Skp2 substrates, and leading to G1-phase cell-cycle arrest and the suppression of cell migration. In lung orthotopic xenografts, SB also significantly decreased Skp2 expression and increased p27/Kip1 protein levels. SB administration inhibited tumor growth and metastasis in lung tissue, thus prolonging survival time in mice without causing obvious toxicity. Thus, SB is a potential Skp2-targeting agent that warrants further clinical investigation.
Zitieren
APA
Zhang, S., Hong, M., Sun, X., Huang, D., He, D., Chen, Y., Yuan, Y., & Liu, Y. (2022). Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2. Acta Materia Medica. https://doi.org/10.15212/amm-2022-0011
Vancouver
Zhang S, Hong M, Sun X, Huang D, He D, Chen Y, et al. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2. Acta Materia Medica. 2022. doi:10.15212/amm-2022-0011
BibTeX
@article{Zhang2022,
author = {Zhang, Shi-Bing and Hong, Ming and Sun, Xiao-Yang and Huang, Da and He, Dan-Hua and Chen, Yu-Fei and Yuan, Yong and Liu, Yong-Qiang},
title = {Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2},
journal = {Acta Materia Medica},
year = {2022},
doi = {10.15212/amm-2022-0011}
}
EUVIMED